AMAG Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
AMAG AMAG Pharmaceuticals Inc
HCI Hci Group Inc
PSF Cohen & Steers Select Preferred and Income Fund
PJT PJT Partners Inc
ALK Alaska Air Group Inc
RS Reliance Steel & Aluminum Co
HFWA Heritage Financial Corp
MET MetLife Inc
KALU Kaiser Aluminum Corp
STBA S&T Bancorp Inc

Health Care : Biotechnology | Small Cap Value
Company profile

AMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.

Closing Price
Day's Change
0.01 (0.07%)
B/A Size
Day's High
Day's Low

10-day average volume:

UPDATE: Fastly stock plunges more than 25% after TikTok fails to use its software as much as anticipated

4:58 pm ET October 14, 2020 (MarketWatch)

By Jeremy C. Owens

Software company shaves millions off third-quarter guidance and will issue a new full-year forecast as largest customer uses product less amid fight with president

Fastly Inc. shares plummeted more than 25% in after-hours trading Wednesday, after the software company said that its largest customer, TikTok parent Bytedance Inc., did not use its product as much as expected amid a threatened ban in the U.S.

Fastly (FSLY)disclosed in a news release that it now expects third-quarter revenue of $70 million to $71 million, after previously guiding for sales of $73.5 million to $75.5 million. The company also said that its full-year guidance should no longer be relied upon, and that a new forecast would be issued when the company fully reports earnings on Oct. 28.

The company stated that its largest customer did not use its products, which charge based on usage, as much as expected "due to the impacts of the uncertain geopolitical environment." While Fastly did not disclose the name of that customer in the release, Fastly has admitted in filings with the Securities and Exchange Commission and elsewhere that its largest customer is Bytedance.

"The current global environment has in some ways fueled our business, but has also created areas of uncertainty," Chief Executive Joshua Bixby said in a statement. "While our preliminary third-quarter results reflect the challenges of a usage-based model, we believe the fundamentals of Fastly's business remain strong, as does demand for our platform."

President Donald Trump has attempted to ban TikTok from operating in the U.S. unless China-based Bytedance transfers ownership to a U.S. entity. While there was an agreement to institute a new entity in the U.S. with help from Oracle Corp. (ORCL) and Walmart Inc. (WMT), that move appears to be on hold as TikTok fights the ban through the U.S. court system, where a judge halted the ban late last month (

For more: The TikTok geopolitical soap opera is a confusing mess (

In its latest quarterly filing with the SEC (, Fastly said that Bytedance was its biggest customer and contributed 12% of its revenue in the first six months of the calendar year. In Wednesday's announcement (, the company also said that other customers used its product less than anticipated at the end of the third quarter.

Fastly stock closed with a 4.4% decline at $123.19 on Wednesday, then plunged to less than $90 a share in after-hours trading following the announcement. The San Francisco software company went public in May 2019 for $16 a share.

-Jeremy C. Owens; 415-439-6400;

(END) Dow Jones Newswires

October 14, 2020 16:58 ET (20:58 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.